Research

Energy balance

Greater weight loss during treatment is associated with a lower likelihood of discontinuing GLP-1 RA, and weight regain after discontinuation is associated with a higher likelihood of reinitiating treatment.

Your weight loss progress directly impacts your likelihood of staying on GLP-1 RA. Greater weight loss correlates with better adherence, while weight regain after stopping often prompts patients to restart. If you experience a plateau, discuss it with your provider rather than stopping abruptly, as continued use may still offer health benefits.

GoodSupportsHIGH confidence
Greater on-treatment weight loss was associated with a lower likelihood of GLP-1 RA discontinuation; similarly, weight gain since discontinuation was associated with an increased likelihood of GLP-1 RA reinitiation.
Patricia J Rodriguez et al. · medRxiv · 2024

Why this rating

Large cohort study with time-varying weight change modeling.

Source

Discontinuation and Reinitiation of GLP-1 Receptor Agonists Among US Adults with Overweight or Obesity

Patricia J Rodriguez et al. · medRxiv · 2024

DOI 10.1101/2024.07.26.24311058

preprint · n=96544Cited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →